Prognostic factors in recurrent glioblastoma patients treated with bevacizumab.

导出原文传递

翻译打印收藏纠错

第一作者： Christina,Schaub

第一单位： Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany.

作者： Christina,Schaub ^[1] ; Julia,Tichy ^[2] ; Niklas,Schäfer ^[1] ; Kea,Franz ^[3] ; Frederic,Mack ^[4] ; Michel,Mittelbronn ^[1] ; Sied,Kebir ^[5] ; Anna-Luisa,Thiepold ^[1] ; Andreas,Waha ^[3] ; Natalie,Filmann ^[2] ; Mohammed,Banat ^[6] ; Rolf,Fimmers ^[7] ; Joachim P,Steinbach ^[8] ; Ulrich,Herrlinger ^[9] ; Johannes,Rieger ^[2] ; Martin,Glas ^[1] ; Oliver,Bähr ^[2]

作者单位： Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany. ^[1] Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Schleusenweg 2-16, 60528, Frankfurt, Germany. ^[2] Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, University of Bonn Medical Center, Bonn, Germany. ^[3] Department of Neurosurgery, Goethe University Hospital, Frankfurt, Germany. ^[4] Institute of Neurology (Edinger-Institute), Goethe University Hospital, Frankfurt, Germany. ^[5] Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. ^[6] Institute of Biostatistics and Mathematical Modeling, Goethe University Hospital Frankfurt, Frankfurt, Germany. ^[7] Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany. ^[8] Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn Medical Center, Bonn, Germany. ^[9] Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany. martin.glas@ukb.uni-bonn.de. ^[10] Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, University of Bonn Medical Center, Bonn, Germany. martin.glas@ukb.uni-bonn.de. ^[11] Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik, Bonn, Germany. martin.glas@ukb.uni-bonn.de. ^[12] Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Schleusenweg 2-16, 60528, Frankfurt, Germany. oliver.baehr@med.uni-frankfurt.de. ^[13]

关键词 Bevacizumab Irinotecan Karnofsky performance score Recurrent glioblastoma Survival